Nu Skin Enterprises, Inc. (NUS) Stock Price & Analysis
Nu Skin Enterprises, Inc. (NUS) rose 2.26% to USD 5.44 as of June 10, 2026 at 09:02 UTC, according to Nexqual real-time market data.
NUS last closed at USD 5.32; the session ranged USD 5.44–5.55 on volume of 448,483 shares. Market capitalization is $264.11M, with a 52-week range of USD 5.19–14.62 (NYQ). Source: Nexqual, June 10, 2026 at 09:02 UTC.
Key Statistics (as of June 10, 2026 at 09:02 UTC)
| Price | USD 5.44 |
|---|---|
| Change | ▲ 2.26% (up) |
| Previous Close | USD 5.32 |
| Open | USD 5.38 |
| Day Range | USD 5.44 – 5.55 |
| 52-Week Range | USD 5.19 – 14.62 |
| Volume | 448,483 shares |
| Market Cap | $264.11M |
| Exchange | NYQ |
Technical Analysis (NUS)
Nexqual's technical model rates NUS "SELL" based on 2 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 09:02 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 24.49 (oversold) |
| vs SMA50 | Below (USD 6.8) |
| MACD | -0.44 (negative) |
Analyst Ratings (NUS)
Wall Street analysts rate NUS "None", per Nexqual as of June 10, 2026 at 09:02 UTC.
| Consensus Rating | None |
|---|---|
| Buy / Hold / Sell | 0 / 0 / 0 |
Earnings (NUS)
| Next Earnings Date | 2026-08-06 |
|---|---|
| EPS Estimate | USD 0.2 |
| Revenue Estimate | $345.20M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.14 vs est 0.15 ▼ miss |
| 2025-12-31 | USD 0.29 vs est 0.3 ▼ miss |
| 2025-09-30 | USD 0.34 vs est 0.3 ▲ beat |
Source: Nexqual, June 10, 2026 at 09:02 UTC.
Financials & Fundamentals (NUS)
| Total Revenue | $1.44B |
|---|---|
| Revenue Growth (YoY) | -12.00% |
| Gross Margin | +69.31% |
| Operating Margin | +1.83% |
| Profit Margin | +3.78% |
| ROE | +7.04% |
| Debt / Equity | 38.19 |
| Current Ratio | 2.04 |
| Total Cash | $200.40M |
| Total Debt | $303.25M |
| Free Cash Flow | $61.60M |
Source: Nexqual, June 10, 2026 at 09:02 UTC.
Financial Health Score (NUS)
Nexqual rates Nu Skin Enterprises, Inc.'s overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 09:02 UTC.
| Growth | Critical — Revenue -14% YoY (annual), sharp decline |
|---|---|
| Profitability | Strong — Gross margin 69%, operating 2% |
| Balance Sheet | Strong — $200M cash vs $303M debt |
| Cash Flow | Mixed — FCF $62M, slim 4.1% margin |
| Efficiency | Mixed — ROE 7%, ROA 3.7% |
Ownership (NUS)
| Insider Ownership | +3.41% |
|---|---|
| Institutional Ownership | +76.63% |
| Shares Outstanding | 48.55M |
| Float | 47.16M |
| Short % of Float | +6.50% |
Source: Nexqual, June 10, 2026 at 09:02 UTC.
Leadership (NUS)
Nu Skin Enterprises, Inc. is led by Ryan S. Napierski (age 51), President, CEO & Director, per Nexqual as of June 10, 2026 at 09:02 UTC.
| President, CEO & Director | Ryan S. Napierski (age 51) |
|---|---|
| Co-Founder & Executive Chairman of the Board | Steven J. Lund (age 72) |
| Executive VP, COO & Chief Legal Officer | Chayce David Clark (age 42) |
| Executive VP & President of Global Sales | Justin S. Keisel (age 51) |
| Interim Chief Financial Officer | Chelsea Lantz (age 41) |
Major Backers & Investors (NUS)
Notable institutional backers of Nu Skin Enterprises, Inc. include American Century Companies Inc, Charles Schwab, Charles Schwab Investment Management, Inc., according to Nexqual as of June 10, 2026 at 09:02 UTC.
Active Investors
| Investor | Stake |
|---|---|
| American Century Companies Inc | 7.94% |
| Charles Schwab | 4.59% |
| Charles Schwab Investment Management, Inc. | 4.41% |
| Prescott Group Capital Management, L.L.C. | 3.7% |
| Acadian Asset Management. LLC | 3.63% |
| Renaissance Technologies | 3.5% |
| AQR Capital Management, LLC | 2.55% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 14.34% |
| BlackRock | 12.09% |
| Dimensional Fund Advisors | 3.57% |
Source: Nexqual, June 10, 2026 at 09:02 UTC.
From Nu Skin Enterprises, Inc.'s Latest SEC 10-K Filing (filed 2026-02-13)
Key Strengths & Strategy (as disclosed to the SEC)
- Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide.
- It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands.
- The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus.
- In addition, it is the research and product development of skin care products, nutritional supplements, and devices.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HLF | Herbalife Ltd. | USD 11.3 | ▼ 1.14% |
| USNA | USANA Health Sciences, Inc. | USD 19.01 | ▲ 5.44% |
| IPAR | Interparfums, Inc. | USD 96.86 | ▲ 6.12% |
| FLO | Flowers Foods, Inc. | USD 7.66 | ▲ 2.41% |
| PII | Polaris Inc. | USD 69.47 | ▲ 5.16% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 09:02 UTC. This page is informational and not investment advice.